NO20013601L - Nye morfolinobenzamidsalter - Google Patents

Nye morfolinobenzamidsalter

Info

Publication number: NO20013601L
Authority: NO; Norway
Prior art keywords: salts; morpholinobenzamide; new; enantiomer; salt
Prior art date: 1999-01-22

Application number

NO20013601A

Other languages

English (en)

Norwegian (no)

Other versions

NO20013601D0 (no

Inventor

Stefan Berg

Daniel Sohn

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-22

Filing date

2001-07-20

Publication date

2001-09-11

2001-07-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-07-20 Publication of NO20013601D0 publication Critical patent/NO20013601D0/no

2001-09-11 Publication of NO20013601L publication Critical patent/NO20013601L/no

Links

HHAZUISNXJLXHR-UHFFFAOYSA-N 2-morpholin-4-ylbenzamide Chemical class NC(=O)C1=CC=CC=C1N1CCOCC1 HHAZUISNXJLXHR-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
150000003839 salts Chemical class 0.000 abstract 3
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20013601A 1999-01-22 2001-07-20 Nye morfolinobenzamidsalter NO20013601L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9900190A SE9900190D0 (sv)	1999-01-22	1999-01-22	New compounds
PCT/SE2000/000079 WO2000043378A1 (en)	1999-01-22	2000-01-14	New morpholinobenzamide salts

Publications (2)

Publication Number	Publication Date
NO20013601D0 NO20013601D0 (no)	2001-07-20
NO20013601L true NO20013601L (no)	2001-09-11

Family

ID=20414186

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013601A NO20013601L (no)	1999-01-22	2001-07-20	Nye morfolinobenzamidsalter

Country Status (28)

Country	Link
US (1)	US6291458B1 (is)
EP (1)	EP1149083A1 (is)
JP (1)	JP2002535320A (is)
KR (1)	KR20010101585A (is)
CN (1)	CN1188405C (is)
AR (1)	AR030145A1 (is)
AU (1)	AU778674B2 (is)
BR (1)	BR0007577A (is)
CA (1)	CA2359105A1 (is)
CZ (1)	CZ20012643A3 (is)
DZ (1)	DZ3002A1 (is)
EE (1)	EE200100381A (is)
HU (1)	HUP0200412A3 (is)
ID (1)	ID30556A (is)
IL (1)	IL144444A0 (is)
IS (1)	IS6007A (is)
MY (1)	MY133438A (is)
NO (1)	NO20013601L (is)
NZ (1)	NZ512684A (is)
PL (1)	PL349775A1 (is)
RU (1)	RU2237668C2 (is)
SE (1)	SE9900190D0 (is)
SK (1)	SK10222001A3 (is)
TN (1)	TNSN00015A1 (is)
TR (1)	TR200102087T2 (is)
UA (1)	UA69438C2 (is)
WO (1)	WO2000043378A1 (is)
ZA (1)	ZA200105491B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0002729D0 (sv) *	2000-07-20	2000-07-20	Astrazeneca Ab	Novel compound form
GT200600414A (es)	2005-09-12	2007-09-20		Sal de glucuranato de compuesto de piperazine
PE20070523A1 (es)	2005-09-12	2007-06-28	Wyeth Corp	Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
GT200600416A (es)	2005-09-12	2007-09-20		Sales salicilato y gentisato de un compuesto de piperazina
US20080033050A1 (en) *	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine
RU2540464C2 (ru) *	2012-05-28	2015-02-10	Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации	Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3919624A1 (de)	1989-06-15	1990-12-20	Boehringer Ingelheim Kg	Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9119692D0 (en) *	1991-09-14	1991-10-30	Smithkline Beecham Plc	Pharmaceuticals
GB9119932D0 (en)	1991-09-18	1991-10-30	Glaxo Group Ltd	Chemical compounds
ES2162792T3 (es)	1991-09-18	2002-01-16	Glaxo Group Ltd	Derivados de benzanilida como antagonistas de 5-ht1d.
GB9119920D0 (en)	1991-09-18	1991-10-30	Glaxo Group Ltd	Chemical compounds
DK148392D0 (da)	1992-12-09	1992-12-09	Lundbeck & Co As H	Heterocykliske forbindelser
GB2273930A (en)	1992-12-30	1994-07-06	Glaxo Group Ltd	Benzanilide derivatives
WO1994021619A1 (en) *	1993-03-16	1994-09-29	Pfizer Inc.	Naphthalene derivatives
JPH09503773A (ja)	1993-10-19	1997-04-15	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	５ｈｔ−１ｄレセプター拮抗剤用のベンズアニリド誘導体
SE9601110D0 (sv) *	1996-03-22	1996-03-22	Astra Ab	Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9702799D0 (sv) *	1997-07-25	1997-07-25	Astra Ab	New compounds

1999
- 1999-01-22 SE SE9900190A patent/SE9900190D0/xx unknown
2000
- 2000-01-09 DZ DZ000004A patent/DZ3002A1/xx active
- 2000-01-14 EP EP00902246A patent/EP1149083A1/en not_active Withdrawn
- 2000-01-14 AU AU23374/00A patent/AU778674B2/en not_active Ceased
- 2000-01-14 CA CA002359105A patent/CA2359105A1/en not_active Abandoned
- 2000-01-14 SK SK1022-2001A patent/SK10222001A3/sk unknown
- 2000-01-14 BR BR0007577-9A patent/BR0007577A/pt not_active IP Right Cessation
- 2000-01-14 CN CNB008030103A patent/CN1188405C/zh not_active Expired - Fee Related
- 2000-01-14 PL PL00349775A patent/PL349775A1/xx not_active Application Discontinuation
- 2000-01-14 TR TR2001/02087T patent/TR200102087T2/xx unknown
- 2000-01-14 IL IL14444400A patent/IL144444A0/xx unknown
- 2000-01-14 WO PCT/SE2000/000079 patent/WO2000043378A1/en not_active Ceased
- 2000-01-14 CZ CZ20012643A patent/CZ20012643A3/cs unknown
- 2000-01-14 JP JP2000594794A patent/JP2002535320A/ja active Pending
- 2000-01-14 KR KR1020017009056A patent/KR20010101585A/ko not_active Ceased
- 2000-01-14 ID IDW00200101578A patent/ID30556A/id unknown
- 2000-01-14 HU HU0200412A patent/HUP0200412A3/hu unknown
- 2000-01-14 EE EEP200100381A patent/EE200100381A/xx unknown
- 2000-01-14 NZ NZ512684A patent/NZ512684A/xx unknown
- 2000-01-14 RU RU2001123433A patent/RU2237668C2/ru not_active IP Right Cessation
- 2000-01-14 UA UA2001085896A patent/UA69438C2/uk unknown
- 2000-01-18 AR ARP000100215A patent/AR030145A1/es unknown
- 2000-01-20 TN TNTNSN00015A patent/TNSN00015A1/fr unknown
- 2000-01-20 MY MYPI20000180A patent/MY133438A/en unknown
- 2000-07-21 US US09/621,387 patent/US6291458B1/en not_active Expired - Fee Related
2001
- 2001-07-03 ZA ZA200105491A patent/ZA200105491B/en unknown
- 2001-07-17 IS IS6007A patent/IS6007A/is unknown
- 2001-07-20 NO NO20013601A patent/NO20013601L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR030145A1 (es)	2003-08-13
TR200102087T2 (tr)	2001-12-21
PL349775A1 (en)	2002-09-09
CN1188405C (zh)	2005-02-09
JP2002535320A (ja)	2002-10-22
HUP0200412A3 (en)	2002-11-28
NO20013601D0 (no)	2001-07-20
IS6007A (is)	2001-07-17
WO2000043378A1 (en)	2000-07-27
SE9900190D0 (sv)	1999-01-22
US6291458B1 (en)	2001-09-18
CZ20012643A3 (cs)	2002-01-16
EE200100381A (et)	2002-12-16
DZ3002A1 (fr)	2004-03-27
TNSN00015A1 (fr)	2005-11-10
CA2359105A1 (en)	2000-07-27
ID30556A (id)	2001-12-20
CN1337956A (zh)	2002-02-27
KR20010101585A (ko)	2001-11-14
SK10222001A3 (sk)	2002-03-05
EP1149083A1 (en)	2001-10-31
HUP0200412A2 (en)	2002-06-29
AU778674B2 (en)	2004-12-16
AU2337400A (en)	2000-08-07
BR0007577A (pt)	2001-10-23
UA69438C2 (en)	2004-09-15
RU2237668C2 (ru)	2004-10-10
MY133438A (en)	2007-11-30
ZA200105491B (en)	2002-10-03
IL144444A0 (en)	2002-05-23
NZ512684A (en)	2003-06-30

Legal Events

Date	Code	Title	Description
2005-10-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO950297D0 (no)	1995-01-26	Prolinamidderivater
CA2382919A1 (en)	2001-04-19	Bicyclic imidazo-3-yl-amine derivatives
NO904839L (no)	1991-05-10	Fremgangsmaate for fremstilling av benzoxazinderivater.
NO964871L (no)	1996-11-15	Nye agonistforbindelser
SE9903760D0 (sv)	1999-10-18	New compounds
NO173139C (no)	1993-11-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
NO20035210L (no)	2003-11-27	2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
DK0734383T3 (da)	2002-10-14	Cykliske amidderivater som neurokinin-A-antagonister
NO942953D0 (no)	1994-08-09	11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
SE9904508D0 (sv)	1999-12-09	New compounds
NO996108L (no)	2000-02-10	9-oksinerytromycinderivater
NO890723D0 (no)	1989-02-21	Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
BR0313407A (pt)	2005-07-05	Novo uso de derivados de benzotiazol
NO331002B1 (no)	2011-09-05	Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
NO20015172L (no)	2002-01-23	1-metyl-erytromycin-derivater
NO20065904L (no)	2007-02-20	Terapeutiske forbindelser
NO20052683L (no)	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO975901L (no)	1998-06-22	Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
NO20061839L (no)	2006-06-26	Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
HU911301D0 (en)	1991-10-28	Process for producing 2,9-disubstituted 4h-pyrido(1,2a)-pyrimidine derivatives and pharmaceutical preparatives containing these compounds as active substance
NO20060147L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
DK0992509T3 (da)	2004-12-20	Nye makrolid-derivater
SE0102440D0 (sv)	2001-07-05	New compound
NO20060146L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
CA2300289A1 (en)	1999-02-04	A pharmaceutical composition active in reducing production of mcp-1 protein